Kringle Pharma, Inc.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Kringle Pharma, Inc. made a loss over the last year. Kringle Pharma, Inc. owes ¥0.37 for every ¥1 it owns. Kringle Pharma, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in Japan · latest annual results Sep 2025.
P/E ratio
LossKringle Pharma, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
3.64The share price is 3.64 times Kringle Pharma, Inc.'s book value per share, higher than 82% of Healthcare companies in Japan.
Market cap
¥4.6 BThe total market value of all of Kringle Pharma, Inc.'s shares at today's price (share price × number of shares), smaller than 81% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥1.3 BWhat Kringle Pharma, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥155.02Net worth divided by the number of shares. The share price of ¥565.00 is 3.6 times this, which is the P/B above.
Return on equity (ROE)
-61.2%Kringle Pharma, Inc. lost 61.2% of its shareholders' money over the last year, lower than 90% of Healthcare companies in Japan.
Owes vs Owns
0.37×Kringle Pharma, Inc. owes ¥0.37 for every ¥1 it owns (low), lower than 51% of Healthcare companies in Japan.
Dividend yield
NoneKringle Pharma, Inc. does not currently pay a dividend.
Revenue growth
-10%Revenue fell 10% in the year to Sep 2025, and shrank 43% a year on average over 3 years.
Profit growth
LossKringle Pharma, Inc. made a loss in each of the last two years.
Profit margin
-1268.8%Kringle Pharma, Inc. lost ¥1269 for every ¥100 of revenue.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Kringle Pharma, Inc.: ¥4.6 B ÷ ¥1.3 B (30 Jun 2026) = 3.6.
What is Kringle Pharma, Inc.'s return on equity?
Kringle Pharma, Inc. lost 61.2% of its shareholders' money over the last year, lower than 90% of Healthcare companies in Japan.
How much does Kringle Pharma, Inc. owe compared with what it owns?
Kringle Pharma, Inc. owes ¥0.37 for every ¥1 it owns (low), lower than 51% of Healthcare companies in Japan.
Does Kringle Pharma, Inc. pay a dividend?
No. Kringle Pharma, Inc. does not currently pay a dividend.
Is Kringle Pharma, Inc.'s revenue growing?
Revenue fell 10% in the year to Sep 2025, and shrank 43% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.